Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes, ...

Over two thirds of patients with hidradenitis suppurativa experience fewer flares, new lesions, and improved quality of life ...

Canadian researchers find that taking semaglutide increases the chances of developing neovascular age-related macular ...

GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...